Study 1: Simultaneous Quantification of TB-500 and Its Metabolites in In-Vitro Experiments and Rats by UHPLC-Q-Exactive Orbitrap MS/MS
Authors: Khandoker Asiqur Rahaman, Anca Raluca Muresan, Hophil Min, Junghyun Son, Hyung-Seop Han, Min-Jung Kang, Oh-Seung Kwon
Source: ScienceDirect
Scientific Findings
Researchers developed and validated an advanced analytical method capable of simultaneously measuring TB-500 and its metabolites using UHPLC-Q-Exactive Orbitrap mass spectrometry. Metabolic profiling was conducted in human serum, enzymatic systems, and rat urine samples.
The investigation identified Ac-LK as the primary metabolite and Ac-LKK as a long-term metabolite. Biological activity testing in fibroblast-based wound-healing assays demonstrated that the metabolite Ac-LKKTE exhibited significant wound-healing activity, while neither TB-500 nor its metabolites displayed measurable cytotoxicity.
Plain English Interpretation
Scientists studied how TB-500 breaks down after exposure to biological systems. They discovered that one specific breakdown product may be responsible for many of the regenerative effects commonly associated with TB-500. The findings suggest that certain metabolites generated from TB-500 may play a more important role than the original peptide itself in supporting cellular repair processes.